SPIN is steered by a Scientific Committee that supervises the good development of the Psoriasis International Network. The coordinators of the Scientific Committee represent the committee within the FRT - Fondation Rene Touraine’s Scientific Board.
The mission of the SPIN Committee is to develop the activities of the network, in particular by proposing international collaborative projects, contributing to continuing medical training in the field of skin inflammation and providing support to the development of national and regional networks.
Coordinators of SPIN Scientific Committee
-
-
President-elect
Phyllis SPULSMD, PhD, Consultant Dermatologist at The Academic Medical Centre of the University of Amsterdam, NL
-
Past-president
Luigi NALDIDirector of Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy
-
President FRT Scientific Board
Luis PUIGMD, PhD, Department of Dermatology, Hospital de la Sanat Creu i Sant Pau, Barcelona, Spain
-
Past-President FRT Scientific Board
Thomas LUGERChair of Department of Dermatology, University of Münster, Germany
Members of the committee (by alphabetical order)
Martine BAGOT
Professor and Chairperson, Dermatology Department and INSERM U976, Hôpital Saint Louis, Paris, France
José Manuel CARRASCOSA
Associate Professor Department of Dermatology, Universitary Hospital Germans Trias I Pujol, Badalona, Spain
Romana CEOVIC
MD, PhD, University Department of Dermatovenerology, Zagreb Clinical Hospital and School of Medicine, Zagreb, Croatia
Elke DE JONG
Dermatologist at University Medical Center Nijmegen St Radboud, The Netherlands
Nejib DOSS
Head of the department of Dermatology – Military Hospital of Tunis, Professor Faculty of Medicine Tunis, Tunisia
Emad ELGAMAL
Professor of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, New Damietta, Egypt
Carsten FLOHR
Professor Carsten Flohr, chair in dermatology and population science, St
John’s Institute of Dermatology, King’s college london
Maria Lorna FREZ
MD, Professor in Dermatology, University of the Philippines College of Medicine – Philippine General Hospital, Philippines
Giampiero GIROLOMONI
Professor of Dermatology and Head of the Dermatology Section in the Department of Medicine at the University of Verona School of Medicine, Verona, Italy
César GONZALEZ
Coordinator Grupo Colombiano de Psoriasis y artritis psoriasica (CoLPsor), Colombia
Alice GOTTLIEB
MD, PhD, Chair of Dermatology, Tufts Medical Centre, Boston, Massachusetts, USA
Christopher EM GRIFFITHS
MD FRCP FMedSci, Professor of Dermatology, The University of Manchester, Manchester Academic Health Science Centre, The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, UK
Jan Gutermuth
Professor Jan Gutermuth studied medicine at the Johannes Gutenberg-University Mainz/ Germany and trained in dermatology and allergology at the Humboldt University Berlin (Charité) and Technische University Munich (TUM).
Rolland GYULAI
MD, PhD, Director and chair of the Department of Dermatology, Venerology and Dermatooncology, University of Pécs, Hungary
Kenji KABASHIMA
Pr. Kenji KABASHIMA, Chairman and Head, Department of Dermatology, Kyoto University Graduate School of Medicine, Japan.
Lajos KEMENY
Professor and Chair of the Department of Dermatology and Allergology, University of Szeged, Hungary
Alur S. KUMAR
Professor and Head of Department, Owaisi Hospital Deccan College of Medical Sciences, Hyderabad, India
Richard LANGLEY
MD, FRCPC, Professor of Medicine (Dermatology) and Director of Research, Division of Dermatology, Department of Medicine, Dalhousie University, Canada
Mark LEBWOHL
MD, Sol and Clara Kest Professor and Chairman, Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY, USA
Fatimata LY
Head of the Dermatology Department at the Institute of Social Hygiene in Dakar, Professor of Dermatology at the University Cheikh Anta Diop of Dakar, Senegal
Alan MENTER
Chair of research for Dermatology at Baylor Research Institute, Clinical Professor of Dermatology at the University of Texas Southwestern Medical School in Dallas and Professor at Texas A&M Health Science Center, College of Medicine, USA
Ulrich MROWIETZ
MD, Head of Psoriasis-Center, Dept. of Dermatology, Venerology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany
Alexander NAST
Department of Dermatology, Venerology and Allergy, Charité – Universitätsmedizin Berlin, Germany
Carle PAUL
Chair of Department of Dermatology, Paul Sabatier University, CHU Larrey, Toulouse, France
Jörg Christoph PRINZ
Univ.-Prof. Dr. med. Univ. Jörg Christoph PRINZ, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
Nélida RAIMONDO
Head of the Department of Dermatology, Air Force Hospital Buenos Aires, Titular Professor of Dermatology at University Maimónides, Buenos Aires, President of the Latin American Society of Psoriasis (SOLAPSO), Argentina
Kristian REICH
Professor of Dermatology at the Georg-August-University Göttingen and at the Dermatologikum Berlin in Germany
Hugo SCHONENBERGER DE OLIVEIRA
MD University Dermatology Clinic, Coimbra University Hospital, Portugal
Lone SKOV
Professor, Consultant, Department of Dermato-Allergology, Gentofte Hospital,
Faculty of Health Sciences, University of Copenhagen, Denmark
Mona STAHLE
Professor of Dermatology and Venereology, Department of Medicine, Solna Karolinska Institute, Stockholm, Sweden
Diamant THAÇI
Professor and Head Comprehensive Center for Inflammation Medicine, University Luebeck, Germany
Jacob THYSSEN
Dr Thyssen is a clinical dermatologist and Professor employed by the
Capital Region and University of Copenhagen in Denmark.
Skaidra VALIUKEVICIENE
Professor and Head of the Department of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
Peter VAN DE KERKHOF
Chief of the Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands
Christian VESTERGAARD
Aarhus University Hospital | AUH · Department of Dermatology
Richard WARREN
NIHR Clinical Senior Lecturer in Dermatology, Dermatology Centre, University of Manchester, Honorary Consultant Dermatologist Salford Royal NHS Foundation Trust, Manchester, UK
ZHENG Min
Professor and Chairman of the Department of Dermatology at Zhejiang University School of Medicine, China
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
- 2019/04/18 Focus on...
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Melissa officinalis ssp. altissima extracts: A therapeutic approach targeting psoriasis in mice.
J Ethnopharmacol.
2020 Jan 10, 246:112208.
Melissa officinalis L., commonly known as lemon balm, is one of the most well known edible and medicinal plants of the Lamiaceae family. It is quoted in almost all known medical treatises, from Antiquity up to modern era, such as Corpus Hippocraticum, Dioscorides' De Materia Medica and later on in medieval medical manuscripts and Pharmacopoeias. Actually, it is widely used as herbal medicine for the relief of mild symptoms of mental stress, to aid sleep and for symptomatic treatment of mild (...)
see on pubmed
Musa acuminata and its bioactive metabolite 5-Hydroxymethylfurfural mitigates quorum sensing (las and rhl) mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa in vitro.
J Ethnopharmacol.
2020 Jan 10, 246:112242.
Musa acuminata, a tropical plant belongs to the family Musaceae. The fruit peels of this plant have been well documented for their therapeutic value in Asia and Africa. It has also been previously reported for numerous biological applications such as antimicrobial, antioxidant, itching, psoriasis and anti-diarrheal activities. Moreover, M. acuminata peels have been well known for its anti-healing and antiseptic properties and most commonly used for healing wounds and heat burns in South (...)
see on pubmed
Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation.
J Ethnopharmacol.
2020 Jan 10, 246:112246.
Kan-Lu-Hsiao-Tu-Tan (KLHTT) is a popular traditional Chinese medicine for treating various inflammatory diseases.
see on pubmed
on Atopic Dermatitis
Black tea dressings - a rapidly effective treatment for facial dermatitis.
Witte M et al.
Black tea dressings - a rapidly effective treatment for facial dermatitis.
J Dermatolog Treat.
2019 Dec , 30, (8):785-789.
Facial dermatitis is a common dermatologic condition. It is usually treated with either topical corticosteroids or calcineurin inhibitors. However, the use of these drugs is limited by side effects, including skin atrophy, local immunosuppression and possible oncogenicity. The aim of the study was to evaluate the use of wet dressings with black tea for treating facial dermatitis. We performed a prospective, open, uncontrolled before-after study enrolling 22 patients with atopic or contact (...)
see on pubmed
Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Artif Cells Nanomed Biotechnol.
2019 Dec , 47, (1):3540-3547.
Allergen-specific immunotherapy is widely used for allergic rhinitis and asthma treatment worldwide. This study explored the efficacy and safety of sublingual immunotherapy (SLIT) with the extracts of ( Drops) on house dust mites (HDM)-induced atopic dermatitis (AD). 239 patients with HDM-induced AD were recruited and exposure to a multi-centre, randomized, double-blind, and placebo-controlled clinical trials for 36 weeks, which were randomly divided into placebo and sublingual Drops (...)
see on pubmed
Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
Arch. Dermatol. Res..
2019 Dec , 311, (10):795-800.
The endocannabinoid system is important for skin homeostasis and alterations are linked to inflammatory diseases like atopic dermatitis (AD). Importantly, activation of cannabinoid receptor CB2 decreases pruritus and inflammation in mouse models. Reduction of inactivation of endogenous cannabinoids could, therefore, be a therapeutic option for AD. Dogs spontaneously develop AD, which closely mimics the human disease making them suitable to test new therapies. Our study aimed to test the (...)
see on pubmed
